NCT04193319 Effect of Fluconazole on PK of Fluzoparib in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT04158700 A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT04148937 A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer Status COMPLETED Phase PHASE1
NCT04146298 Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT04141397 Real-world Clinical Effectiveness of Whole Genome and Transcriptome Analysis to Guide Advanced Cancer Care Status UNKNOWN Phase N/A
NCT04124666 Clinical Study of Granulocyte Infusion for Advanced Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT04121676 Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT04121039 Study of the Apatinib Combine With POF Versus POF in Gastric Cancer Status UNKNOWN Phase PHASE2
NCT04110223 Validation Studies of Biomarkers for Precision Radiation Oncology in Locally Advanced Solid Tumors Status UNKNOWN Phase N/A
NCT04095208 Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study Status COMPLETED Phase PHASE2
NCT04089306 Integration of Palliative Care in an Oncology and Hematology Unit Status UNKNOWN Phase N/A
NCT04071262 A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer Status COMPLETED Phase PHASE1
NCT04065984 Body Composition Manipulation in CoLorectal cancEr (BiCyCLE): Neuromuscular Electrical Stimulation (NMES) Status ACTIVE_NOT_RECRUITING Phase NA
NCT04042597 Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma Status UNKNOWN Phase PHASE2
NCT04001010 Safety and Efficacy of Inhaled Synthetic THC/CBD for Improving Physical Functioning and for Modulating Cachexia Progression in Patients With Advanced Cancer and Associated Cachexia Status SUSPENDED Phase PHASE3
NCT03994601 An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT03980041 Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275) Status COMPLETED Phase PHASE2